InvestorsHub Logo
Followers 163
Posts 19577
Boards Moderated 2
Alias Born 12/09/2004

Re: BIOChecker4 post# 292563

Tuesday, 01/12/2021 1:57:56 PM

Tuesday, January 12, 2021 1:57:56 PM

Post# of 458325
The situation that is holding the share price down hasn't changes in any material way.

The MOA is still unproven in many peoples eyes. The paradigm is still novel and unaccepted by the general biotech investor. The company doesn't have an approved drug, has not applied for an NDA yet. And the relatively low volume does make the share price vulnerable to manipulation by the usual market forces. The only completed placebo controlled trial has not yet released a full report for detailed analysis.

Trial results are all that matter.... still.

“The American Republic will endure until the day Congress discovers that it can bribe the public with the public’s money

-Alexis De Tocqueville

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News